Aditxt, Inc. (ADTX) Cash Flow Statement
Where ADTX’s cash came from and went, 2025
December 31, 2025 · U.S. dollars- Cash from operations
- −$25.69B
- Capital expenditures
- $13.7M 430,140.8% of revenue
- Free cash flow
- −$25.70B −804,447,636.9% margin
- Returned to shareholders
- $9.2M
- Change in cash
- $2.37B cash at year-end $3.20B
Drawn to scale: where the cash came from and how it was used. Hover for values.
ADTX operating cash flow, capex and free cash flow
ADTX cash flow trends, 2017–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$386,2632017 | −$25.69B2025 | — | |
| Capital expenditures | $170,6292017 | $13.7M2025 | +73.1%/yr | |
| Free cash flow | −$556,8922017 | −$25.70B2025 | — | |
| Free cash flow margin | −22,177.5%2021 | −804,447,636.9%2025 | −804,425,459.5 pts | |
| Stock-based compensation | $612,3442017 | $473.3M2025 | +129.6%/yr | |
| Share buybacks (net) | $02018 | $9.2M2025 | — | |
| Capex / revenue | 967.1%2021 | 430,140.8%2025 | +429,173.8 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ADTX cash flow by activity
ADTX net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
ADTX cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating activities | |||||||||
| Net income | −$42.79B | −$34.4M | −$32.4M | −$27.6M | −$46.4M | −$9.1M | −$5.8M | −$5.7M | −$851,944 |
| Depreciation & amortization | $272.6M | $617,251 | $542,583 | $535,977 | $476,236 | $17,773 | $17,773 | $17,773 | $17,773 |
| Stock-based compensation | $473.3M | $6.7M | $1.4M | $3.1M | $4.6M | $3.2M | $4.2M | $3.5M | $612,344 |
| Change in working capital | −$6.2M | $7.1M | $9.1M | −$493,437 | $129,975 | −$1.6M | $1.1M | $1.4M | $205,336 |
| Other non-cash items | $16.36B | $3.2M | $2.8M | $2.1M | $18.8M | $300,000 | −$17,773 | $332,734 | −$369,772 |
| Cash from operating activities | −$25.69B | −$16.8M | −$18.6M | −$22.4M | −$22.3M | −$7.2M | −$464,352 | −$386,263 | −$386,263 |
| Investing activities | |||||||||
| Capital expenditures | −$13.7M | −$1 | −$14,407 | −$367,079 | −$1.0M | −$170,629 | −$170,629 | −$170,629 | −$170,629 |
| Investments (net) | $0 | −$5.0M | −$14,407 | −$241,918 | −$16.3M | −$170,629 | — | — | — |
| Acquisitions & other investing | −$2.42B | $1 | $14,407 | $367,079 | $1.0M | $170,629 | $0 | $0 | $0 |
| Cash from investing activities | −$2.44B | −$5.0M | −$14,407 | −$241,918 | −$16.3M | −$170,629 | −$170,629 | −$170,629 | −$170,629 |
| Financing activities | |||||||||
| Share repurchases & issuance (net) | −$9.2M | −$2.9M | −$1,000 | −$20,000 | $0 | — | $470,180 | $631,220 | — |
| Net borrowing (repayment) | −$5.5M | −$1.4M | $5.8M | −$812,378 | $2.9M | −$340,600 | $1,998 | $119,502 | $119,502 |
| Shares issued | $44.1M | $21.2M | $11.1M | $17.3M | $29.9M | $18.5M | $470,177 | $631,220 | $0 |
| Other financing | $30.46B | $5.6M | −$261,160 | $1.1M | $3.2M | −$271,070 | −$589,622 | −$904,970 | −$19,502 |
| Cash from financing activities | $30.49B | $22.5M | $16.5M | $17.5M | $36.0M | $17.9M | $352,733 | $476,972 | $100,000 |
| Summary | |||||||||
| Net change in cash | $2.37B | $735,929 | −$2.7M | −$5.1M | −$2.6M | $10.5M | −$111,619 | $90,709 | $100,000 |
| Cash at end of period | $3.20B | $833,031 | $97,102 | $2.8M | $7.9M | $10.5M | $4,090 | $115,709 | $100,000 |
| Free cash flow | −$25.70B | −$16.8M | −$18.6M | −$22.8M | −$23.3M | −$7.4M | −$464,352 | −$386,263 | −$556,892 |
| Free cash flow margin | −804,447,636.9% | −12,510.4% | −2,881.6% | −2,437.5% | −22,177.5% | — | — | — | — |
| Capex / revenue | 430,140.8% | 0.0% | 2.2% | 39.3% | 967.1% | — | — | — | — |
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$16.2M | −$5.2M | −$24.2M | −$7.4M | −$6.0M | −$5.5M | −$7.0M | −$7.5M | −$14.7M | −$11.0M | −$9.7M | −$5.7M |
| Depreciation & amortization | $48,716 | $67,640 | $67,799 | $67,882 | $69,283 | $166,368 | $149,088 | $158,030 | $143,765 | $132,922 | $136,361 | $136,654 |
| Stock-based compensation | $0 | $472.8M | −$10,000 | $473,311 | $10,000 | $4,369 | $32 | $4,097 | $6.7M | $745,347 | $153,992 | $163,228 |
| Change in working capital | −$270,984 | −$4.3M | $829,285 | $3.3M | −$6.0M | −$632,019 | $1.9M | $4.6M | $1.2M | $4.9M | $676,662 | $1.9M |
| Other non-cash items | $11.8M | −$472.7M | $21.0M | $1.2M | $187,139 | −$138,536 | $2.5M | $482,448 | $705,413 | $1.8M | $744,956 | $176,286 |
| Cash from operating activities | −$4.6M | −$9.2M | −$2.3M | −$2.4M | −$11.7M | −$6.1M | −$2.4M | −$2.3M | −$6.0M | −$3.3M | −$8.0M | −$3.3M |
| Investing activities | ||||||||||||
| Capital expenditures | −$10,379 | −$13,747 | −$4 | $0 | $0 | $0 | −$4 | −$4 | −$1 | $0 | −$9,356 | −$2 |
| Investments (net) | — | $2.4M | $0 | −$2.4M | $0 | −$2.7M | −$1.3M | −$1.0M | $0 | $0 | −$9,356 | −$2 |
| Acquisitions & other investing | $0 | −$2.4M | $2.4M | $0 | — | $0 | $4 | $4 | — | — | $9,356 | $2 |
| Cash from investing activities | −$10,379 | −$13,743 | $2.4M | −$2.4M | — | −$2.7M | −$1.3M | −$1.0M | — | — | −$9,356 | −$2 |
| Financing activities | ||||||||||||
| Dividends paid | — | −$2.7M | −$1.4M | — | −$1.4M | — | — | — | — | — | — | — |
| Share repurchases & issuance (net) | −$369,996 | −$1.6M | −$316,632 | −$308,000 | −$7.0M | — | $0 | $0 | −$1,000 | — | — | — |
| Net borrowing (repayment) | $1.4M | −$3.1M | $89,126 | $356,237 | −$2.9M | −$3.4M | $1.2M | — | — | — | — | $1.5M |
| Shares issued | $603,261 | $16.8M | $2.6M | $4.6M | $20.2M | $15.0M | $3.2M | $2.4M | $600,000 | $507,016 | $10.0M | $0 |
| Other financing | $0 | $2.9M | $1.2M | $0 | $2.5M | −$2.2M | −$502,840 | $873,861 | $5.4M | $1.2M | −$443,163 | $1.6M |
| Cash from financing activities | $1.7M | $12.3M | $2.2M | $4.7M | $11.4M | $9.4M | $3.9M | $3.3M | $6.0M | $1.8M | $9.6M | $3.1M |
| Summary | ||||||||||||
| Net change in cash | −$2.9M | $3.0M | −$160,638 | −$152,737 | −$356,615 | $504,435 | $237,373 | $2,552 | −$8,431 | −$1.6M | $1.6M | −$206,556 |
| Cash at end of period | $268,852 | $3.2M | $163,041 | $323,679 | $476,416 | $833,031 | $328,596 | $91,223 | $88,671 | $97,102 | $1.7M | $95,953 |
| Free cash flow | −$4.6M | −$9.3M | −$2.3M | −$2.4M | −$11.7M | −$6.1M | −$2.4M | −$2.3M | −$6.0M | −$3.3M | −$8.0M | −$3.3M |
| Free cash flow margin | −37,742.3% | −2,178,686.1% | −313,442.5% | −237,523.6% | −1,150,628.2% | −193,606.0% | −34,495.5% | −5,171.8% | −7,481.1% | −4,070.6% | −6,461.2% | −1,485.1% |
| Capex / revenue | 85.4% | 3,234.6% | 0.5% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 7.5% | 0.0% |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
ADTX cash generation
In fiscal 2025 (ended December 31, 2025), Aditxt generated -$25.7 billion of cash from operations and spent $13.7 million on capital expenditures, leaving free cash flow of -$25.7 billion, −804,447,636.9% of revenue. It returned $9.2 million to shareholders through dividends ($0) and net share buybacks ($9.2 million). Cash and equivalents rose by $2.4 billion over the year.
Related: ADTX income statement, ADTX balance sheet. See the ADTX stock overview for the latest quote and news.
ADTX cash flow FAQ
What is Aditxt's free cash flow?
Aditxt's free cash flow was -$25.7 billion in fiscal 2025: -$25.7 billion of operating cash flow minus $13.7 million of capital expenditures It was -$16.8 million a year earlier..
How much cash does Aditxt generate from operations?
Aditxt generated -$25.7 billion of cash from operating activities in fiscal 2025.
How much does Aditxt spend on capital expenditures?
Aditxt spent $13.7 million on capital expenditures in fiscal 2025, 430,140.8% of revenue, compared with $0.0 million the year before.
How much stock does Aditxt buy back?
Aditxt spent $9.2 million on net share repurchases in fiscal 2025.